Chemical Watch has been sold to Enhesa
Arrowpoint Advisory’s TMT sector team has advised the shareholders of Chemical Watch on its sale to Enhesa.
Founded in 2007, and headquartered in Shrewsbury, Chemical Watch is the leading global provider of independent intelligence and insights for product safety professionals managing chemicals. Distinguished by its journalistic approach, Chemical Watch is a trusted partner to businesses around the world making complex chemicals management decisions.
Enhesa is a global environmental, health and safety compliance intelligence platform and the deal marks the first add-on acquisition for Enhesa since mid-market private equity firm CGE backed the company in July 2020.
Mamta Patel and Julian Rose, Co-Founders of Chemical Watch, said: “We are delighted that we chose Arrowpoint Advisory to handle the sale for us. They were by our side throughout, giving us clear strategic advice and supporting us through this important process. It was also clear from the start that they had a deep knowledge of the information services sector and had taken the time to really understand our business which meant that they were highly effective advocates for us.”
Richard Fetterman, Managing Director at Arrowpoint Advisory, concluded: “We are very pleased to have advised the Chemical Watch shareholders on its sale to Enhesa and very much enjoyed working with them. The transaction further demonstrates the strong appeal of high-quality, subscription-led, information services businesses and it represents yet another strong credential for Arrowpoint Advisory in the space.”
Contact the deal team
DISCOVER our sell-side transactions
Sell-side M&A Advisory Services
We deliver hands-on, full-service sell-side mergers and acquisitions (M&A) strategies for private company owners, financial sponsors and blue-chip corporates across our core sectors.